By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


DelMar Pharmaceuticals 

999 West Broadway
Suite 720
  British Columbia  V5Z 1K5  Canada
Phone: 1-604-629-5989 Fax:



Company News
BIO2015 EXCLUSIVE: DelMar Pharmaceuticals Files for $8M Fund Raise, BioSpace (DHX) Learns 6/17/2015 12:13:51 PM
DelMar Pharmaceuticals Invited To Present At The World NSCLC Summit On June 23-24, 2015 6/15/2015 8:09:21 AM
BIO2015: DelMar Pharmaceuticals To Present At The BIO International Convention On June 17, 2015 6/10/2015 8:04:14 AM
DelMar Pharmaceuticals To Present At The Small-Cap Stars Spring Conference 2015 At Convene In Times Square New York On June 10 6/4/2015 10:20:23 AM
ASCO15 EXCLUSIVE: Experimental Brain Cancer Drugs Heads to Phase II/III Trial This Year: DelMar Pharmaceuticals CEO 6/2/2015 8:04:17 AM
ASCO15: DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data On VAL-083 In Refractory Glioblastoma Multiforme (GBM) At ASCO 6/1/2015 5:04:20 PM
DelMar Pharmaceuticals To Host Investor Conference Call On June 1, 2015 To Discuss New VAL-083 Phase I/II Clinical Data In Patients With Refractory Glioblastoma Multiforme 6/1/2015 11:34:44 AM
DelMar Pharmaceuticals Presents Additional Data On The Potential Of VAL-083 In The Treatment Of Temozolomide-Resistant Glioblastoma Multiforme 5/29/2015 6:43:13 AM
DelMar Pharmaceuticals Announces Upcoming Investor And Scientific Conference Presentations 5/27/2015 8:16:06 AM
DelMar Pharmaceuticals Announces Third Quarter Fiscal Year 2015 Financial Results And Provides Corporate Update 5/18/2015 10:41:13 AM